New Treatment Option for CLL Patients with Poorest Prognosis

New Treatment Option for CLL Patients with Poorest Prognosis

Uncategorized July 29, 2014 at 1:53 PM 0 comments

Patients with a particularly difficult-to-treat form of chronic lymphocytic leukaemia have gained access to a new treatment option in the US after regulators expanded the use of Janssen Biotech/Pharmacyclics’ Imbruvica (ibrutinib). After a priority review, the US Food and Drug Administration has issued a green light for the drug’s useRead More

Taking B Vitamins Won’t Prevent Alzheimer’s Disease

Uncategorized July 17, 2014 at 1:48 PM 0 comments

Taking B vitamins doesn’t slow mental decline as we age, nor is it likely to prevent Alzheimer’s disease, conclude Oxford University researchers who have assembled all the best clinical trial data involving 22,000 people to offer a final answer on this debate. High levels in the blood of a compoundRead More

Calls for UK to Pilot New Reimbursement Models for Antibiotics

Calls for UK to Pilot New Reimbursement Models for Antibiotics

Uncategorized July 9, 2014 at 1:46 PM 0 comments

Pharmaceutical industry leaders are calling for an alternative reimbursement model for antibiotics in the UK sooner rather than later in order to support effective stewardship and research and development in the short term. The call, from the Association of the British Pharmaceutical Industry’s Antibiotic Network, comes after concerns were raisedRead More

Drug Shows Promise for Effectively Treating Metabolic Syndrome

Uncategorized July 4, 2014 at 5:40 PM 0 comments

University of Utah researchers have discovered that an enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome, a finding that has a U of U spinoff company developing a drug to potentially treat the condition. The researchers, led by Jared Rutter, Ph.D., professor of biochemistry, hopeRead More

World GI Press Release: Phase III Trial Shows Improved Survival with TAS-102 in Metastatic Colorectal Cancer Refractory to Standard Therapies

Uncategorized June 29, 2014 at 9:31 AM 0 comments

The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona Barcelona/Lugano “Around 50% of patients with colorectal cancer develop metastases but eventuallyRead More

UK Starts World’s Largest Dementia Study with Two Million People

UK Starts World’s Largest Dementia Study with Two Million People

Uncategorized June 19, 2014 at 4:28 PM 0 comments

The UK is launching the world’s largest study into dementia, involving more than two million people, through the Medical Research Council and industry partners, while Alzheimer’s Research UK has pledged £100 million over five years to tackle the problem. These are just two of a variety of initiatives launched atRead More

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

Uncategorized June 11, 2014 at 12:36 PM 0 comments

Key findings point to significant differences between treated and untreated people living with HIV RESEARCH TRIANGLE PARK, N.C., June 10, 2014 /PRNewswire/ — ViiV Healthcare today announced new survey data that provide important insights that may help explain why HIV treatment rates remain low in the United States. Findings from the online survey, conductedRead More

‘Tomato Pill’ Improves Function of Blood Vessels in Patients with Cardiovascular Disease

Uncategorized June 10, 2014 at 3:41 PM 0 comments

A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the University of Cambridge. The incidence of cardiovascular disease varies worldwide, but is notably reduced in southern Europe, where a ‘Mediterranean diet’ consisting ofRead More

Anti-Diabetic Drug Slows Aging and Lengthens Lifespan

Uncategorized June 4, 2014 at 2:45 PM 0 comments

A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world’s most widely used anti-diabetic drug, slows ageing and increases lifespan. In experiments reported in the journal Proceedings of the National Academy of Sciences, the researchers tease out the mechanism behindRead More

New Way to Treat HER2-Positive Breast Cancer

Uncategorized May 27, 2014 at 11:47 AM 0 comments

Scientists at Cold Spring Harbor Laboratory (CSHL) have reported a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer. The breast cancer subtype in question is commonly called “HER2-positive”; it’s a subset of the disease affecting aboutRead More